{"schema_version":"bookimed.page-context.v1","id":"tricuspid-valve-disease","url":"https://hub.bookimed.com/heart-surgery/tricuspid-valve-disease/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/tricuspid-valve-disease.json","index_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/index.json","full_dataset_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/content.json","content_revision":"source-driven-rankings-20261008","date_modified":"2026-10-08","language":"en","kind":"guide","title":"Tricuspid valve disease: repair, replacement and catheter options","summary":"Tricuspid treatment depends on leakage or narrowing, symptoms and right-heart function. Medicines relieve congestion; surgical or catheter treatment can address the valve in selected patients.","research_credit":{"name":"Yevhenii Kozlov","role":"Co-Founder of Bookimed","url":"https://us-uk.bookimed.com/ceo/kozlov/","contribution":"Research personally prepared and reviewed","assistance":"AI tools assisted source research."},"editorial_scope":"Source-based patient information; an individual treatment plan requires clinical review.","research_method":"How this guide is researched and compared Research project led by Yevhenii Kozlov . We link clinical guidance, primary studies and named hospital or offer sources beside the relevant statements. Comparisons distinguish individual operators from programme results and preserve the study population, follow-up and limitations. Prices are dated examples with their stated scope. Research and editorial preparation are separate from clinical review; no named clinician has medically reviewed this edition. Bookimed provides care coordination. Partner and reference programmes are identified from their sources; paid ordering is not used in our published-cohort comparison. Read the editorial policy .","key_takeaways":[{"label":"A mild leak may need no procedure","text":"More significant disease is assessed alongside right-ventricular function, lung pressures and contributing conditions.","sources":["DX06"]},{"label":"Catheter treatment still has risks","text":"Tricuspid replacement can improve patient outcomes but serious bleeding and permanent pacing occurred in the FDA evidence.","sources":["DX09"]},{"label":"Another valve operation changes the decision","text":"The 2025 European guidance includes concomitant treatment of severe tricuspid regurgitation during left-sided valve surgery.","sources":["DX01"]}],"benefits":[{"text":"Surgical repair can preserve a suitable valve, while catheter options extend treatment to selected patients at high surgical risk.","sources":["DX01","DX07"]}],"limitations":[{"text":"Advanced right-ventricular dysfunction, pulmonary vascular disease and unsuitable leaflet anatomy can limit benefit or feasibility.","sources":["DX01"]}],"sections":[{"id":"benefit-balance","title":"Benefits and trade-offs","text":"Benefits and trade-offs Potential advantages Surgical repair can preserve a suitable valve, while catheter options extend treatment to selected patients at high surgical risk. Sources: 2025 ESC/EACTS valvular heart disease guideline: official recommendation slides · Tricuspid valve repair and replacement Trade-offs and limits Advanced right-ventricular dysfunction, pulmonary vascular disease and unsuitable leaflet anatomy can limit benefit or feasibility. Sources: 2025 ESC/EACTS valvular heart disease guideline: official recommendation slides","links":[{"label":"2025 ESC/EACTS valvular heart disease guideline: official recommendation slides","url":"https://yjxzhi.files.cmp.optimizely.com/download/f718bde6bfbc11f08f5ddabefdf356e7"},{"label":"Tricuspid valve repair and replacement","url":"https://www.mayoclinic.org/tests-procedures/tricuspid-valve-repair-tricuspid-valve-replacement/about/pac-20385087"},{"label":"2025 ESC/EACTS valvular heart disease guideline: official recommendation slides","url":"https://yjxzhi.files.cmp.optimizely.com/download/f718bde6bfbc11f08f5ddabefdf356e7"}]},{"id":"diagnosis","title":"A small leak and advanced right-heart disease need different answers","text":"A small leak and advanced right-heart disease need different answers A trace or mild leak may need no procedure. With more important regurgitation, the assessment includes right-heart size and pumping function, lung pressures, congestion and related heart disease. Leakage can arise from diseased leaflets or enlargement of the chambers and valve ring. Pacemaker leads, left-sided valve disease and atrial fibrillation can contribute. Repair or replacement must address that mechanism to work. Sources: Tricuspid valve regurgitation: diagnosis and treatment · 2020 ACC/AHA valve guideline: mitral stenosis and tricuspid disease","links":[{"label":"Tricuspid valve regurgitation: diagnosis and treatment","url":"https://www.mayoclinic.org/diseases-conditions/tricuspid-valve-regurgitation/diagnosis-treatment/drc-20350173"},{"label":"2020 ACC/AHA valve guideline: mitral stenosis and tricuspid disease","url":"https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2020/12/16/22/00/2020-ACC-AHA-VHD-GL-Pt-2-GL-VHD"}]},{"id":"options","title":"What each treatment is trying to do","text":"What each treatment is trying to do Treatment Potential benefit Limitation Medicines Reduce congestion and manage contributing disease Do not mechanically repair a leaking valve Surgical repair Preserve the native valve Requires a feasible durable reconstruction Surgical replacement Treat an inadequately repairable valve Introduces prosthesis-related long-term care Tricuspid TEER Reduce regurgitation with catheter-delivered leaflet clips Requires suitable leaflet anatomy; residual leakage can remain Catheter replacement Replace a valve without conventional surgical access in selected patients Anatomy, device availability and procedural risk restrict eligibility Sources: Tricuspid valve regurgitation: diagnosis and treatment · Tricuspid valve repair and replacement · EVOQUE transcatheter tricuspid replacement: FDA approval overview","links":[{"label":"Tricuspid valve regurgitation: diagnosis and treatment","url":"https://www.mayoclinic.org/diseases-conditions/tricuspid-valve-regurgitation/diagnosis-treatment/drc-20350173"},{"label":"Tricuspid valve repair and replacement","url":"https://www.mayoclinic.org/tests-procedures/tricuspid-valve-repair-tricuspid-valve-replacement/about/pac-20385087"},{"label":"EVOQUE transcatheter tricuspid replacement: FDA approval overview","url":"https://www.fda.gov/medical-devices/recently-approved-devices/edwards-evoque-tricuspid-valve-replacement-system-p230013"}],"tables":[[["Treatment","Potential benefit","Limitation"],["Medicines","Reduce congestion and manage contributing disease","Do not mechanically repair a leaking valve"],["Surgical repair","Preserve the native valve","Requires a feasible durable reconstruction"],["Surgical replacement","Treat an inadequately repairable valve","Introduces prosthesis-related long-term care"],["Tricuspid TEER","Reduce regurgitation with catheter-delivered leaflet clips","Requires suitable leaflet anatomy; residual leakage can remain"],["Catheter replacement","Replace a valve without conventional surgical access in selected patients","Anatomy, device availability and procedural risk restrict eligibility"]]]},{"id":"timing","title":"Do not leave referral until only the valve grade is considered","text":"Do not leave referral until only the valve grade is considered The 2025 European guideline supports considering catheter treatment for symptomatic severe regurgitation despite optimal medical therapy in patients at high surgical risk, without severe right-ventricular dysfunction or pre-capillary pulmonary hypertension. Suitability still depends on anatomy and specialist assessment. When left-sided valve surgery is planned, severe tricuspid regurgitation generally calls for treatment during the same operation; repair should also be considered for moderate regurgitation. This can address both valve problems in one surgical admission. Sources: 2025 ESC/EACTS valvular heart disease guideline: official recommendation slides","links":[{"label":"2025 ESC/EACTS valvular heart disease guideline: official recommendation slides","url":"https://yjxzhi.files.cmp.optimizely.com/download/f718bde6bfbc11f08f5ddabefdf356e7"}]},{"id":"stenosis","title":"If the report says tricuspid stenosis","text":"If the report says tricuspid stenosis Stenosis restricts blood entering the right ventricle and may coexist with leakage. It needs a separate discussion from clip treatment for regurgitation. Severe symptomatic stenosis, or severe stenosis during a left-sided valve intervention, is a surgical indication in the 2025 European guidance. Balloon treatment can widen selected narrowed tricuspid valves; associated leakage and valve anatomy can make surgery more appropriate. Congenital conditions such as Ebstein anomaly and tricuspid atresia follow their own specialist pathways. Sources: 2025 ESC/EACTS valvular heart disease guideline: official recommendation slides · Tricuspid valve disease: diagnosis and treatment · Tricuspid valve repair and replacement Congenital heart disease ↗","links":[{"label":"2025 ESC/EACTS valvular heart disease guideline: official recommendation slides","url":"https://yjxzhi.files.cmp.optimizely.com/download/f718bde6bfbc11f08f5ddabefdf356e7"},{"label":"Tricuspid valve disease: diagnosis and treatment","url":"https://www.mayoclinic.org/diseases-conditions/tricuspid-valve-disease/diagnosis-treatment/drc-20573710"},{"label":"Tricuspid valve repair and replacement","url":"https://www.mayoclinic.org/tests-procedures/tricuspid-valve-repair-tricuspid-valve-replacement/about/pac-20385087"},{"label":"Congenital heart disease ↗","url":"https://hub.bookimed.com/heart-surgery/congenital-heart-surgery/"}]},{"id":"risk","title":"A better scan is one outcome; feeling and living better are others","text":"A better scan is one outcome; feeling and living better are others Reduced leakage on a scan, better daily function, fewer admissions and longer survival are separate outcomes. FDA evidence for EVOQUE describes benefits alongside serious early complications, including bleeding and permanent pacing. Right-ventricular function, pulmonary pressures and kidney or liver disease affect the balance of benefit and risk. A catheter procedure does not eliminate major cardiac risks. Sources: EVOQUE transcatheter tricuspid replacement: FDA approval overview · Tricuspid valve repair and replacement · Tricuspid valve regurgitation: diagnosis and treatment Compare clinics ↗ Specialists ↗ Recovery ↗","links":[{"label":"EVOQUE transcatheter tricuspid replacement: FDA approval overview","url":"https://www.fda.gov/medical-devices/recently-approved-devices/edwards-evoque-tricuspid-valve-replacement-system-p230013"},{"label":"Tricuspid valve repair and replacement","url":"https://www.mayoclinic.org/tests-procedures/tricuspid-valve-repair-tricuspid-valve-replacement/about/pac-20385087"},{"label":"Tricuspid valve regurgitation: diagnosis and treatment","url":"https://www.mayoclinic.org/diseases-conditions/tricuspid-valve-regurgitation/diagnosis-treatment/drc-20350173"},{"label":"Compare clinics ↗","url":"https://hub.bookimed.com/heart-surgery/tricuspid-valve-clinics/"},{"label":"Specialists ↗","url":"https://hub.bookimed.com/heart-surgery/tricuspid-valve-surgeons/"},{"label":"Recovery ↗","url":"https://hub.bookimed.com/heart-surgery/recovery/"}]},{"id":"matching-specialists","title":"Specialists for this treatment pathway","text":"Specialists for this treatment pathway Explore each specialist’s clinical focus, current programme and the studies relevant to this treatment. The listed roles include cardiac surgeons and, where appropriate, interventional cardiologists. JD Rochester, Minnesota · United States cardiac surgeon Joseph A. Dearani → Dearani’s surgical practice includes Ebstein anomaly and congenital tricuspid-valve reconstruction at Mayo. Mayo Clinic Rochester → Sources: Mayo Clinic · Joseph Dearani View expertise and research → Portrait source ↗ New York · United States interventional cardiologist Susheel K. Kodali → Kodali is an NYU interventional cardiologist specialising in catheter valve therapies, including tricuspid treatment. His trial work examines symptoms and quality of life alongside bleeding and pacemaker risks. NYU Langone → Sources: Susheel K. Kodali, MD — physician profile · NYU welcomes Susheel Kodali to lead interventional cardiology · Transcatheter Valve Replacement in Severe Tricuspid Regurgitation. View expertise and research → Browse the full specialist directory →","links":[{"label":"Joseph A. Dearani →","url":"https://hub.bookimed.com/heart-surgery/doctor-joseph-dearani/"},{"label":"Mayo Clinic Rochester →","url":"https://hub.bookimed.com/heart-surgery/clinic-mayo-rochester/"},{"label":"Mayo Clinic · Joseph Dearani","url":"https://www.mayoclinic.org/biographies/dearani-joseph-a-m-d/bio-20053326"},{"label":"View expertise and research →","url":"https://hub.bookimed.com/heart-surgery/doctor-joseph-dearani/"},{"label":"Portrait source ↗","url":"https://nyulangone.org/doctors/1659455335/susheel-k-kodali"},{"label":"Susheel K. Kodali →","url":"https://hub.bookimed.com/heart-surgery/doctor-susheel-kodali/"},{"label":"NYU Langone →","url":"https://hub.bookimed.com/heart-surgery/clinic-nyu-langone/"},{"label":"Susheel K. Kodali, MD — physician profile","url":"https://nyulangone.org/doctors/1659455335/susheel-k-kodali"},{"label":"NYU welcomes Susheel Kodali to lead interventional cardiology","url":"https://nyulangone.org/news/nyu-langone-names-sunil-rao-md-director-leon-h-charney-division-cardiology-and-welcomes-susheel-kodali-md-lead-interventional-cardiology"},{"label":"Transcatheter Valve Replacement in Severe Tricuspid Regurgitation.","url":"https://pubmed.ncbi.nlm.nih.gov/39475399/"},{"label":"View expertise and research →","url":"https://hub.bookimed.com/heart-surgery/doctor-susheel-kodali/"},{"label":"Browse the full specialist directory →","url":"https://hub.bookimed.com/heart-surgery/tricuspid-valve-surgeons/"}]}],"introduction":"Heart surgery guide / Tricuspid valve disease Tricuspid valve disease · Decision guide Tricuspid valve disease: repair, replacement and catheter options Understand the cause and severity of a tricuspid leak, when to compare surgery with catheter treatment, and why right-heart function matters. Research by Yevhenii Kozlov · Co-Founder of Bookimed Updated 8 October 2026 Sources linked throughout At a glance Tricuspid treatment depends on leakage or narrowing, symptoms and right-heart function. Medicines relieve congestion; surgical or catheter treatment can address the valve in selected patients. A mild leak may need no procedure More significant disease is assessed alongside right-ventricular function, lung pressures and contributing conditions. Sources: Tricuspid valve regurgitation: diagnosis and treatment Catheter treatment still has risks Tricuspid replacement can improve patient outcomes but serious bleeding and permanent pacing occurred in the FDA evidence. Sources: EVOQUE transcatheter tricuspid replacement: FDA approval overview Another valve operation changes the decision The 2025 European guidance includes concomitant treatment of severe tricuspid regurgitation during left-sided valve surgery. Sources: 2025 ESC/EACTS valvular heart disease guideline: official recommendation slides","related_documents":[{"id":"heart-surgery","title":"Heart surgery abroad: treatments, clinics and costs","kind":"home","url":"https://hub.bookimed.com/heart-surgery/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/heart-surgery.json"},{"id":"heart-valve-surgery","title":"Heart valve surgery: repair, replacement and catheter options","kind":"guide","url":"https://hub.bookimed.com/heart-surgery/heart-valve-surgery/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/heart-valve-surgery.json"},{"id":"clinics","title":"Heart surgery clinics: compare techniques and specialist teams","kind":"directory","url":"https://hub.bookimed.com/heart-surgery/clinics/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/clinics.json"},{"id":"surgeons","title":"Find cardiac surgeons and heart specialists by procedure","kind":"surgeons","url":"https://hub.bookimed.com/heart-surgery/surgeons/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/surgeons.json"},{"id":"recovery","title":"Recovery after heart surgery: hospital, home and travel","kind":"guide","url":"https://hub.bookimed.com/heart-surgery/recovery/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/recovery.json"},{"id":"second-opinion","title":"Prepare for a heart surgery second opinion","kind":"inquiry","url":"https://hub.bookimed.com/heart-surgery/second-opinion/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/second-opinion.json"},{"id":"congenital-heart-surgery","title":"Congenital heart surgery: children and adults","kind":"guide","url":"https://hub.bookimed.com/heart-surgery/congenital-heart-surgery/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/congenital-heart-surgery.json"},{"id":"doctor-joseph-dearani","title":"Joseph A. Dearani: HCM and congenital heart surgery","kind":"doctor-profile","url":"https://hub.bookimed.com/heart-surgery/doctor-joseph-dearani/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/doctor-joseph-dearani.json"},{"id":"doctor-susheel-kodali","title":"Susheel K. Kodali: transcatheter tricuspid valve treatment","kind":"doctor-profile","url":"https://hub.bookimed.com/heart-surgery/doctor-susheel-kodali/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/doctor-susheel-kodali.json"},{"id":"clinic-nyu-langone","title":"NYU Langone: heart surgery expertise","kind":"clinic-profile","url":"https://hub.bookimed.com/heart-surgery/clinic-nyu-langone/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/clinic-nyu-langone.json"},{"id":"clinic-mayo-rochester","title":"Mayo Clinic Rochester: heart surgery expertise","kind":"clinic-profile","url":"https://hub.bookimed.com/heart-surgery/clinic-mayo-rochester/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/clinic-mayo-rochester.json"},{"id":"tricuspid-valve-surgeons","title":"Tricuspid valve specialists","kind":"specialist-directory","url":"https://hub.bookimed.com/heart-surgery/tricuspid-valve-surgeons/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/tricuspid-valve-surgeons.json"},{"id":"tricuspid-valve-clinics","title":"Tricuspid valve treatment clinics and specialist centres","kind":"clinic-directory","url":"https://hub.bookimed.com/heart-surgery/tricuspid-valve-clinics/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/tricuspid-valve-clinics.json"}],"sources":{"DX01":{"id":"DX01","title":"2025 ESC/EACTS valvular heart disease guideline: official recommendation slides","url":"https://yjxzhi.files.cmp.optimizely.com/download/f718bde6bfbc11f08f5ddabefdf356e7","publisher":"European Society of Cardiology / EACTS","published":"2025-08-29","source_type":"Official guideline recommendation tables; pages 68–77 inspected","read_at":"2026-10-08"},"DX03":{"id":"DX03","title":"2020 ACC/AHA valve guideline: mitral stenosis and tricuspid disease","url":"https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2020/12/16/22/00/2020-ACC-AHA-VHD-GL-Pt-2-GL-VHD","publisher":"American College of Cardiology","published":"2020-12-17","source_type":"Official guideline summary; body inspected; newer 2025 ESC guidance also used","read_at":"2026-10-08"},"DX06":{"id":"DX06","title":"Tricuspid valve regurgitation: diagnosis and treatment","url":"https://www.mayoclinic.org/diseases-conditions/tricuspid-valve-regurgitation/diagnosis-treatment/drc-20350173","publisher":"Mayo Clinic","published":null,"source_type":"Official hospital patient information; current body inspected","read_at":"2026-10-08"},"DX07":{"id":"DX07","title":"Tricuspid valve repair and replacement","url":"https://www.mayoclinic.org/tests-procedures/tricuspid-valve-repair-tricuspid-valve-replacement/about/pac-20385087","publisher":"Mayo Clinic","published":"2026-06-17","source_type":"Official hospital procedure information; body inspected","read_at":"2026-10-08"},"DX08":{"id":"DX08","title":"Tricuspid valve disease: diagnosis and treatment","url":"https://www.mayoclinic.org/diseases-conditions/tricuspid-valve-disease/diagnosis-treatment/drc-20573710","publisher":"Mayo Clinic","published":"2024-10-03","source_type":"Official hospital information; body inspected","read_at":"2026-10-08"},"DX09":{"id":"DX09","title":"EVOQUE transcatheter tricuspid replacement: FDA approval overview","url":"https://www.fda.gov/medical-devices/recently-approved-devices/edwards-evoque-tricuspid-valve-replacement-system-p230013","publisher":"US Food and Drug Administration","published":"2024-02-01","source_type":"Regulator device approval overview; body inspected","read_at":"2026-10-08"},"depth-dearani":{"title":"Mayo Clinic · Joseph Dearani","url":"https://www.mayoclinic.org/biographies/dearani-joseph-a-m-d/bio-20053326","publisher":"Official hospital / clinical programme","read_at":"2026-10-08","label":"Mayo Clinic · Joseph Dearani","retrieval":"Official profile body via web search; direct HTTP route returned 403"},"SP11":{"title":"Susheel K. Kodali, MD — physician profile","publisher":"NYU Langone Health","url":"https://nyulangone.org/doctors/1659455335/susheel-k-kodali","read_at":"2026-10-08","source_kind":"official-institution","local_body":"/Users/eugen/Projects/frankenstein-agentic-framework/outputs/heart-surgery-hub-20261007/review/provider-depth/specialties/sources/kodali-profile.txt","supports":"Adult interventional cardiologist, current NYU role, aortic/mitral/tricuspid transcatheter therapies and trial leadership.","limitations":"He is not a cardiac surgeon. Earlier Columbia trial affiliations are historical."},"SP12":{"title":"NYU welcomes Susheel Kodali to lead interventional cardiology","publisher":"NYU Langone Health","url":"https://nyulangone.org/news/nyu-langone-names-sunil-rao-md-director-leon-h-charney-division-cardiology-and-welcomes-susheel-kodali-md-lead-interventional-cardiology","read_at":"2026-10-08","source_kind":"official-institution","local_body":"/Users/eugen/Projects/frankenstein-agentic-framework/outputs/heart-surgery-hub-20261007/review/provider-depth/specialties/sources/kodali-move.txt","supports":"NYU appointment and move from Columbia; director of interventional cardiology and Manhattan catheterization laboratory.","limitations":"","published_at":"2026-08-27"},"SP20":{"title":"Transcatheter Valve Replacement in Severe Tricuspid Regurgitation.","publisher":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39475399/","read_at":"2026-10-08","published_at":"2024-10-30","doi":"10.1056/nejmoa2401918","pmid":"39475399","source_kind":"primary-research-abstract","local_body":"/Users/eugen/Projects/frankenstein-agentic-framework/outputs/heart-surgery-hub-20261007/review/provider-depth/specialties/sources/pmid-39475399.json","supports":"TRISCEND II, 400 randomized severe symptomatic TR patients; replacement plus medical therapy improved composite at one year, principally symptoms and quality of life.","limitations":"Multicentre device-specific trial, not individual/NYU performance; higher severe bleeding and new pacemaker rates; no claim of established survival benefit. Funded by Edwards Lifesciences."}}}